PE20040084A1 - Combinaciones de medicamentos que contienen compuestos heterociclicos y un nuevo agente anticolinergico - Google Patents

Combinaciones de medicamentos que contienen compuestos heterociclicos y un nuevo agente anticolinergico

Info

Publication number
PE20040084A1
PE20040084A1 PE2003000366A PE2003000366A PE20040084A1 PE 20040084 A1 PE20040084 A1 PE 20040084A1 PE 2003000366 A PE2003000366 A PE 2003000366A PE 2003000366 A PE2003000366 A PE 2003000366A PE 20040084 A1 PE20040084 A1 PE 20040084A1
Authority
PE
Peru
Prior art keywords
phenyl
ethyl
containing heterocyclic
heterocyclic compounds
drug combinations
Prior art date
Application number
PE2003000366A
Other languages
English (en)
Inventor
Rolf Banholzer
Christopher John Montague Meade
Helmut Meissner
Gerd Morschhauser
Georg Speck
Michael Pieper
Gerald Pohl
Richard Reichl
Michel Pairet
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of PE20040084A1 publication Critical patent/PE20040084A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Abstract

SE REFIERE A UNA SAL DE FORMULA I DONDE X- ES UN ANION MONOCARGADO NEGATIVAMENTE SELECCIONADO DEL GRUPO DE Cl, Br, I, METANOSULFONATO, NITRATO, MALEATO, FUMARATO ENTRE OTROS EN COMBINACION CON UN COMPUESTO DE FORMULA II DONDE R1 ES H, METILO, ETILO, n-BUTILO, i-BUTILO, FENILO, 2-ETILFENILO, BENCILO, ENTRE OTROS; R2 ES H, METILO, ETILO O JUNTO CON R1, UN PUENTE BUTILENO O PENTILENO; R3 ES H; R4 ES METOXI; R5 ES CICLOHEXILO, FENILO, 3-METOXICARBONILFENILO, 4-METOXICARBONILFENILO, 3-CARBOXIFENILO, 4-CARBOXIFENILO, CN, -COOH, ENTRE OTROS; A ES O, -CH2-; B ES O, -C(R12)(R13)-, ENTRE OTROS; D ES -CH2-CH2-, -CH(Ph)-CH2-, -CONH-, -CO-CH2, ENTRE OTROS; R12 ES H, METILO, ETILO, I-PROPILO, FENILO ENTRE OTROS; R13 ES H O, JUNTO CON R2, UN ENLACE SENCILLO O UN PUENTE BUTILENO. LA COMBINACION MENCIONADA PUEDE ESTAR CONTENIDA EN UNA UNICA FORMA DE ADMINISTRACION O EN DOS FORMAS DE ADMINISTRACION SEPARADAS Y SON UTILES PARA EL TRATAMIENTO DE ENFERMEDADES DE LAS VIAS RESPIRATORIAS
PE2003000366A 2002-04-12 2003-04-10 Combinaciones de medicamentos que contienen compuestos heterociclicos y un nuevo agente anticolinergico PE20040084A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10216427A DE10216427A1 (de) 2002-04-12 2002-04-12 Arzneimittelkompositionen enthaltend heterocyclische Verbindungen und ein neues Anticholinergikum

Publications (1)

Publication Number Publication Date
PE20040084A1 true PE20040084A1 (es) 2004-04-01

Family

ID=28458800

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2003000366A PE20040084A1 (es) 2002-04-12 2003-04-10 Combinaciones de medicamentos que contienen compuestos heterociclicos y un nuevo agente anticolinergico

Country Status (8)

Country Link
US (1) US20040002502A1 (es)
AR (1) AR039404A1 (es)
AU (1) AU2003221562A1 (es)
DE (1) DE10216427A1 (es)
PE (1) PE20040084A1 (es)
TW (1) TW200406209A (es)
UY (1) UY27759A1 (es)
WO (1) WO2003087049A2 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040048887A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
US20040044020A1 (en) * 2002-07-09 2004-03-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors
US20040166065A1 (en) 2002-08-14 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US8603296B2 (en) 2002-10-07 2013-12-10 Georgia-Pacific Consumer Products Lp Method of making a fabric-creped absorbent cellulosic sheet with improved dispensing characteristics
US7494563B2 (en) 2002-10-07 2009-02-24 Georgia-Pacific Consumer Products Lp Fabric creped absorbent sheet with variable local basis weight
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US7332175B2 (en) * 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
EP1504756A1 (en) * 2003-08-06 2005-02-09 Kyowa Hakko Kogyo Co., Ltd Medicament compositions comprising a heterocyclic compound and an anticholinergic
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
US20050272726A1 (en) * 2004-04-22 2005-12-08 Boehringer Ingelheim International Gmbh Novel medicaments for the treatment of respiratory diseases
US7220742B2 (en) * 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
US20050255050A1 (en) * 2004-05-14 2005-11-17 Boehringer Ingelheim International Gmbh Powder formulations for inhalation, comprising enantiomerically pure beta agonists
JP5270343B2 (ja) * 2005-08-15 2013-08-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ベータミメティックスの製造方法
US7599861B2 (en) 2006-03-02 2009-10-06 Convergys Customer Management Group, Inc. System and method for closed loop decisionmaking in an automated care system
US8379830B1 (en) 2006-05-22 2013-02-19 Convergys Customer Management Delaware Llc System and method for automated customer service with contingent live interaction
US7809663B1 (en) 2006-05-22 2010-10-05 Convergys Cmg Utah, Inc. System and method for supporting the utilization of machine language

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2540633A1 (de) * 1975-09-12 1977-04-28 Boehringer Sohn Ingelheim Neue quartaere n-beta-substituierte benzilsaeure-n-alkyl-nortropinester und verfahren zu deren herstellung
US5770738A (en) * 1992-03-05 1998-06-23 Boehringer Ingelheim Kg Esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
JP4172817B2 (ja) * 1995-05-19 2008-10-29 協和醗酵工業株式会社 含酸素複素環化合物
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
US6706726B2 (en) * 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
US20020193393A1 (en) * 2001-03-07 2002-12-19 Michel Pairet Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US7084153B2 (en) * 2002-04-12 2006-08-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising steroids and a novel anticholinergic
US7417051B2 (en) * 2002-04-12 2008-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments comprising betamimetics and a novel anticholinergic
US20040048887A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and EGFR kinase inhibitors
US20040048886A1 (en) * 2002-07-09 2004-03-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on new anticholinergics and NK1 receptor antagonists
US20040044020A1 (en) * 2002-07-09 2004-03-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on novel anticholinergics and p38 kinase inhibitors
US20040058950A1 (en) * 2002-07-09 2004-03-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical compositions based on anticholinergics and PDE-IV inhibitors
US20040166065A1 (en) * 2002-08-14 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation comprising an anticholinergic
US7244742B2 (en) * 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US7332175B2 (en) * 2003-05-27 2008-02-19 Boehringer Ingelheim International Gmbh Long-acting drug combinations for the treatment of respiratory complaints
US7273603B2 (en) * 2003-07-11 2007-09-25 Boehringer Ingelheim International Gmbh HFC solution formulations containing an anticholinergic
TWI259994B (en) * 2003-07-21 2006-08-11 Ali Corp Adaptive multiple levels step-sized method for time scaling
DE10345065A1 (de) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum
US20050154006A1 (en) * 2004-01-09 2005-07-14 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on a scopineester and nicotinamide derivatives
US20050186175A1 (en) * 2004-02-20 2005-08-25 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on benzilic acid esters and soluble TNF receptor fusion proteins

Also Published As

Publication number Publication date
TW200406209A (en) 2004-05-01
AU2003221562A1 (en) 2003-10-27
US20040002502A1 (en) 2004-01-01
WO2003087049A3 (de) 2004-02-05
AR039404A1 (es) 2005-02-16
UY27759A1 (es) 2003-11-28
DE10216427A1 (de) 2003-10-23
AU2003221562A8 (en) 2003-10-27
WO2003087049A2 (de) 2003-10-23

Similar Documents

Publication Publication Date Title
PE20040084A1 (es) Combinaciones de medicamentos que contienen compuestos heterociclicos y un nuevo agente anticolinergico
AR055669A1 (es) Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales.
ECSP105253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
AR058587A1 (es) Compuestos de pirrolo-1,5-naftiridinona,su uso como agentes antibacterianos, composiciones farmaceuticas que los contienen y compuestos intermediarios para preparar dichos compuestos
DK1697371T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
NO20050569L (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
AR078201A1 (es) Compuestos de 2-piridona y su uso en el tratamiento de enfermedades mediadas por la elastasa de neutrofilos
AR057554A1 (es) Derivados de carbamoilbenzotriazol como inhibidores de lipasas y fosfolipasas
EA200870089A1 (ru) Применение производных бензоконденсированного гетероциклического сульфамида для лечения злоупотребления психоактивным веществом и аддикции
HRP20080660T3 (en) Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
AR050711A1 (es) Derivados arilsulfonilestilbeno para el tratamiento y/o prevencion de afecciones del sistema nervioso central
HRP20090264T1 (en) Phenyl-piperazin methanone derivatives
AR044830A1 (es) Derivados de 4,5 diaril -3-heterociclilpirazin- 2- ester
ATE361918T1 (de) 4-(4-methoxybenzyl)-n&#39;-(5-nitro-1,3-thiazol-2- yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
ATE444069T1 (de) Chinolin-derivate zur behandlung von mglur5- rezeptor-vermittelten erkrankungen
DE602006020666D1 (de) Methoden und Zusammensetzungen zur Beruhigung von Mund- und Nasenschleimhäuten
PE20070169A1 (es) Derivados del 4,5-diarilpirrol como antagonistas de receptores cb1
PE20050393A1 (es) Compuestos de benzopirano para uso en el tratamiento y la prevencion de afecciones relacionadas con la inflamacion
DK1656131T3 (da) Anvendelse af betain til behandling claudicatio intermittens
RU2010150451A (ru) Стимуляторы ргц и их комбинации для лечения нарушения слуха
AR056269A1 (es) Derivados de tioamidas, isomeros de los mismos, o las sales farmaceuticamente aceptables de los mismos, como el antagonista receptor vaniloide; y una composicion farmaceutica conteniendo los mismos
AR060307A1 (es) Medicamentos
RU2007143434A (ru) 4-анилино-3-хинолинкарбонитрилы, подходящие для лечения раковых заболеваний
RU2004126145A (ru) N-{[(2s)-4-(3,4-дифторбензил)морфолин-2ил]-метил}-2-{3- [(метилсульфонил)амино]фени л}ацетамид в качестве антагониста ccr-3 для лечения восполительных состояний

Legal Events

Date Code Title Description
FA Abandonment or withdrawal